HH&L Acquisition Co. (HHLA) Stock

About HH&L Acquisition Co.

HH&L Acquisition Co. currently maintains no substantive business operations. Its primary objective is to engage in a strategic business combination, such as a merger, asset purchase, or share exchange, with one or more existing entities. The firm has a particular interest in seeking out opportunities within the healthcare or health-related industries located across various Asian markets. Established in 2020, HH&L Acquisition Co. operates from its headquarters in Central, Hong Kong.

HH&L Acquisition Co. is headquartered in HK.

HH&L Acquisition Co. (HHLA) stock trades at $10.75 with a market capitalization of $156.83M. The stock is valued at a price-to-earnings (P/E) ratio of 11.20, price-to-book of 1.36, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.22 and $11.30, and currently trades 4.9% below its 52-week high.

On profitability, HH&L Acquisition Co. generates a return on equity (ROE) of 10.10%, return on capital employed of -1.08%.

Official website: www.hopuhl.com

HH&L Acquisition Co. by the numbers, 2020–2022

Between 2020 and 2022 HH&L Acquisition Co. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit was $40.0M in 2022.

On a trailing twelve-month basis to Sep '23, revenue is $0 and net profit $18.0M.

Borrowings stand at $1.0M, cash on hand is $123,334, cash from operations was $-1.0M in the latest year, positive in 0 of the last 3.

Return on equity has averaged 5.0% over five years, and was 9.8% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

HH&L Acquisition Co. (HHLA) — frequently asked questions